| Literature DB >> 32629963 |
Masuda Begum Sampa1, Md Rakibul Hoque2, Rafiqul Islam3, Mariko Nishikitani3, Naoki Nakashima3, Fumihiko Yokota4, Kimiyo Kikuchi5, Md Moshiur Rahman6, Faiz Shah7, Ashir Ahmed1.
Abstract
Medical staff carry an inordinate risk of infection from patients, and many doctors, nurses, and other healthcare workers are affected by COVID-19 worldwide. The unreached communities with noncommunicable diseases (NCDs) such as chronic cardiovascular, respiratory, endocrine, digestive, or renal diseases became more vulnerable during this pandemic situation. In both cases, Remote Healthcare Systems (RHS) may help minimize the risk of SARS-CoV-2 transmission. This study used the WHO guidelines and Design Science Research (DSR) framework to redesign the Portable Health Clinic (PHC), an RHS, for the containment of the spread of COVID-19 as well as proposed corona logic (C-Logic) for the main symptoms of COVID-19. Using the distributed service platform of PHC, a trained healthcare worker with appropriate testing kits can screen high-risk individuals and can help optimize triage to medical services. PHC with its new triage algorithm (C-Logic) classifies the patients according to whether the patient needs to move to a clinic for a PCR test. Through modified PHC service, we can help people to boost their knowledge, attitude (feelings/beliefs), and self-efficacy to execute preventing measures. Our initial examination of the suitability of the PHC and its associated technologies as a key contributor to public health responses is designed to "flatten the curve", particularly among unreached high-risk NCD populations in developing countries. Theoretically, this study contributes to design science research by introducing a modified healthcare providing model.Entities:
Keywords: COVID-19; developing countries; portable health clinic; remote healthcare system; unreached communities
Mesh:
Year: 2020 PMID: 32629963 PMCID: PMC7370203 DOI: 10.3390/ijerph17134709
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Death rates with preexisting medical conditions in China [1,15].
| Preexisting Conditions | Confirmed Death Rates | All Cases (Suspected and Asymptomatic) of COVID-19 |
|---|---|---|
| Cardiovascular disease | 13.2% | 10.5% |
| Diabetes | 9.2% | 7.3% |
| Chronic respiratory disease | 8.0% | 6.3% |
| Hypertension | 8.4% | 6.0% |
| Cancer | 7.6% | 5.6% |
| No preexisting conditions | 0.9% |
Figure 1Portable Health Clinic (PHC) system architecture.
Figure 2Primary screening and triaging COVID-19 potential patients by using Portable Health Clinic (PHC).
C-Logic: corona logic designed for a portable health clinic system.
| No. | Symptoms | Healthy | Suspicious | Affected | Emergent |
|---|---|---|---|---|---|
| Green | Yellow | Orange (Consultation) | Red (Emergency) | ||
| 1 | Fever | <37.5 °C | ≥37.5 °C, Continue ≤3 days * | ≥37.5 °C, Continue ≥4 days ** | |
| 2 | muscle or joint pain | No | Continue ≤3 days * | Continue ≥4 days ** | |
| 3 | Sore throat | No | Continue ≤3 days * | Continue ≥4 days ** | |
| 4 | Dyspnea | No | Light to Moderate, Continue ≤3 days * | Light to Moderate, Continue ≥4 days ** | |
| or Severe | |||||
| 5 | Shortness of Breath | ≤15/min | ≤20/min | ≤25/min | ≥26/min |
| 6 | Cough | No | Continue ≤3 days * | Continue ≥4 days ** | |
| 7 | Chillness | No | Continue ≤3 days * | Continue ≥4 days ** | |
| 8 | SpO2 (%) | ≥96% | ≤95%, With no Symptom | ≤95%, With Light to Moderate Dyspnea | ≤95%, With severe Dyspnea |
| 9 | Fatigue | No | Light to Moderate, Continue ≤3 days * | Light to Moderate, Continue ≥4 days ** | |
| or Severe | |||||
| 10 | Loss of appetite | No | Continue ≤3 days * | Continue ≥4 days ** | |
| 11 | Diarrhea | No | Continue ≤3 days* | Continue ≥4 days ** | |
| 12 | Loss of taste | No | Yes | ||
| 13 | Loss of smell sense | No | Yes |
Note: “3 days *” should be replaced by “1 day” and “4 days **” should be replaced by “2 days” for 65 years old or older patients with NCDs such as diabetes, heart failure, COPD, etc. who are using hemodialysis, immunosuppressants, and anticancer agents. No. 8, SpO2 is optional.
Portable health clinic functionalities during general mode and emergency mode.
| Activity | General Mode | Emergency Mode |
|---|---|---|
| Symptom Collection | Health Worker | Mobile Phone or App |
| Clinical Measurements | Health Worker | Patients Self-Test or Health Worker |
| Medical Consultancy | Remote Doctor | Remote Doctor |
| ePrescription | GramHealth Application, printed by eHealth worker | GramHealth Application or Medical Facilities |